NetZealous LLC Services in the Life Sciences Industry

1
NetZealous LLC Services in the Life Sciences
Industry
2

• The life sciences industry in the US is at a kind
  of crossroads today. It is considered an
  independent industry, but its workings and
  dynamics have to take into consideration
  industries that make up the components of the
  life sciences industry, such as pharmaceuticals,
  biotechnology, healthcare and medical devices or
  medical technology.

3
(No Transcript)
4

• Assessments and calculations of the life sciences
  industry are made in collation with these
  industries. The many challenges and changes that
  take place in these industries have to all be
  studied before coming to any meaningful
  conclusions. Most of these industries are
  intertwined to each other, as a result of which
  any analysis of the life sciences industry is
  comprehensive and rounded.

5

• It has to also be noted that the industries that
  are considered a part of the life sciences
  industry have their unique challenges and issues
  based on the geographies in which they are based.

6
Global trends for the industry and for the US

• The life sciences industry has been growing
  steadily globally. Deloitte estimated that the
  global growth of the life sciences industry was a
  little over five percent, a figure it is expected
  to maintain till at least 2018. That is, this was
  the percentage at which the worlds spending on
  healthcare grew in 2015 from the previous year.

7

• This is a mixed bag when it comes to the
  geographies in which this spend was observed. At
  very close to the five percent mark, North
  Americas position was third in this list, ahead
  of South America and Western Europe, and lower
  than that of Asia, Middle East and Africa.

8

• The size of the pharma market makes up the lions
  share of the life sciences industry, taking up
  1.23 trillion of the total global life sciences
  market of 1.883 trillion for 2014, or about two
  thirds of the entire market. Medical technology
  was a 364 billion market, while biotechnologys
  size was 289 billion.

9
Prominent challenges for the life sciences
industry in the US

• As of the end of 2015, the life sciences
  industry, as it exists in the US, faced these
  major challenges

10
Changes in the market conditions

• The market situation for the life sciences
  industry is going through a churn at this point
  of time. The most important change for the
  American life sciences industry is the change in
  emphasis from delivery to value. Patients are no
  longer content with just provision of services.
  They look for value added services.

11

• This has forced players in the life sciences
  industry to alter their outlook towards services
  delivery. They now have to conceive newer and
  innovative methods in healthcare delivery.

12

• As a result, there has been a major rejig of the
  market forces, with smaller companies in the life
  sciences industry being bought over or acquired
  by bigger ones, resulting in a state of flux in
  the consolidation of the industry.

13
Impact of healthcare reforms

• The Affordable Care Act (ACA) is considered among
  legislations with the most far-reaching changes
  to the American healthcare sector. Its provisions
  play out for years to come. One of the immediate
  impacts of the passage of Obamacare, as the ACA
  is also known, is that it brings millions of
  uninsured Americans into the healthcare net.

14

• The industry has to absorb the cost of providing
  healthcare to these millions. In the process of
  doing this, it is sure to go through earthshaking
  changes of a nature or on a scale not imagined
  earlier.

15
(No Transcript)
16
Staying compliant with regulation

• Regulatory compliance is a challenge for any
  industry. It is all the more so for the life
  sciences industry, in which the industries that
  are part of are subject to some of the harshest
  regulatory requirements. Staying compliant with
  regulatory requirements is accepted to be the
  surest means to ensuring that not only products
  and services safe but that it also makes great
  business sense.

17

• The benevolence of the requirements
  notwithstanding the process of adhering to
  regulatory expectations is daunting for the life
  sciences industry. It has to grapple with not
  only the existing regulatory framework, but has
  to also tune itself to the upcoming ones.

18
Pressures on pricing of products

• This has become a major challenge for the life
  sciences industry, especially pharmaceuticals,
  because along with the emphasis on valued added
  care, another major pressure for the life
  sciences industry, especially pharmaceuticals, is
  that of pricing. All over the world, there has
  been a predilection towards generic drugs.

19

• This has dealt heavy pressure on branded
  pharmaceutical products, whose manufacturers are
  now forced to adapt what they see as the most
  optimal means for keeping prices low in order to
  compete with generic drugs. Many well established
  pharmaceutical companies have been selling
  generic drugs of the same molecules for which
  they also sell branded drugs. Such is the
  pressure they are under to survive in his highly
  competitive market.

20
Advent of new technologies and devices

• Any new technology is sure to bring about
  disruptive changes. The area of life sciences
  cannot be and different. New technologies such as
  cloud storage and the rapid rise of handheld
  medical devices and the social media as a means
  of sharing information have caused a major
  shakeup in the industry.

21

• The full effects of these changes will be
  unfolded in the future, but as of now, on account
  of these changes the life sciences industry is
  now in a state of uncertainty and flux.

22

• NetZealous LLC has the right thinking and grasp
  of the challenges and prospects of the life
  sciences industry in the US and the world. As a
  supplier of vital professional trainings that
  help the life sciences industry meet its
  challenges and supplies updates of the latest
  happenings and knowledge to professionals who
  work in the industry

23

• NetZealous LLC is a premier, preferred provider
  of relevant, meaningful and flexible regulatory
  trainings for the life sciences industry.
  Professionals in the life sciences industry
  benefit in a big manner from NetZealous LLCs
  professional trainings.

24
NetZealous LLC offers professional trainings in
all the areas of life sciences. These include

• Medical devices
• Clinical trials
• Quality
• Pharmaceuticals
• Healthcare
• Biologics

• Biotechnology
• HIPAA
• HITECH
• DEA due diligence
• Clinical management
• Risk analysis and risk assessment, etc.

25
Follow Us